Vivos (RDGL) EBT Growth (1y) (2011 - 2025)
Vivos (RDGL) EBT Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -18.50% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 11.26% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -8.83% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 44.35% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 5.78% |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -27.02% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 103.34% |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 74.66% |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 54.33% |
| 10 | Vivos | - | - | -3,105.00 | -5.41% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5.41% |
| Sep 30, 2025 | 38.53% |
| Jun 30, 2025 | -28.22% |
| Mar 31, 2025 | -49.44% |
| Dec 31, 2024 | 4.93% |
| Sep 30, 2024 | -23.60% |
| Jun 30, 2024 | 44.22% |
| Mar 31, 2024 | -124.93% |
| Dec 31, 2023 | -52.51% |
| Sep 30, 2023 | -140.99% |
| Jun 30, 2023 | -14.60% |
| Mar 31, 2023 | 64.52% |
| Dec 31, 2022 | -295.92% |
| Sep 30, 2022 | -37.73% |
| Jun 30, 2022 | 57.66% |
| Mar 31, 2022 | -142.86% |
| Dec 31, 2021 | 41.00% |
| Sep 30, 2021 | -48.36% |
| Jun 30, 2021 | -1,069.29% |
| Mar 31, 2021 | 20.00% |